Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
edge technology, research and clinical immunotherapeutic programs. New personnel will be trained in project specific techniques and procedures. As a successful candidate, you will: · Manufacture
-
-paced lab involved in cutting edge technology, research and clinical immunotherapeutic programs. New personnel will be trained in project specific techniques and procedures. As a successful candidate
-
Fellowship within the laboratory of Dr Ed Boas, at the Beckman Research Institute of City of Hope. For more information on his research please visit here . We are looking for a biomedical engineer, materials
-
labs involved in cutting edge technology, research, and clinical immunotherapeutic programs. Dr. Lior Goldberg’s lab currently has an opening for a Postdoctoral Fellow who will develop chimeric antigen
-
malignancies using engineered cellular therapies. We are looking for a highly motivated candidate with a PhD and/or MD degree interested in combining novel rational and combinatorial synthetic biology approaches
-
structural analyses. Perform in vitro (cell culture) and in vivo (xenograft and PDX) cancer disease modeling. Participate in novel technology development, including CRISPR gene tiling, single-cell CRISPR
-
candidate, you will: Develop and modify laboratory protocols for brain tumor research. Conduct tissue culture, including the characterization and development of murine and human cell lines. Perform in vivo
-
technology, research, and clinical cellular immunotherapy programs, including cell viability, Flow Cytometry, ELISA, qPCR, ddPCR, potency, and cytotoxicity assays. The QCA II will also receive training
-
qualifications should include: · PhD degree in applied biostatistics/statistics or related field. Demonstrable record of accomplishments and peer-reviewed publications. City of Hope is an equal opportunity
-
well as disease relapse in order to design novel inhibitors to intervene the malignancies; 3) collaborative analyses of myeloid cancers genomics using high-throughput single-cell technology. The group conducts